• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 15-07-2026: Press Release

    15-07-2026 | 08:40 am

    Sun Pharma has secured approval to manufacture and market its generic semaglutide in South Africa for type 2 diabetes. This key market entry follows India, highlighting the company's capability in complex generics and expanding access to vital diabetes treatment. Launch is planned shortly.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited